Abstracts
Showing 807 abstracts.
Pharmacokinetics (PK) of high-dose lopinavir (LPV)/Ritonavir (r) with and without saquinavir (SQV) or non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV infected pediatric and adolescent patients previously treated with protease inhibitors (P
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1038
Authors
Brian Robbins, Peter Havens, Edmund Capparelli, Ellen Gould Chadwick, Ram Yogev, Leslie Serchuck, Carol J. Worrell, Carmelita Alvero, Barbara E. HeckmanNelfinavir pharmacokinetics (625 mg tablets) during the third trimester of pregnancy and post-partum.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1026S
Authors
Jennifer S. Read, Brookie M. Best, Alice M. Stek, ChengCheng Hu, Edmund Capparelli, Diane Holland, Sandra K. Burchett, Elizabeth (Betsy) Smith, Mark MirochnickNon-linear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 observed in HIV-1-infected children.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Authors
William T. Shearer, Jaime G. Deville, Pearl Samson, John ( Jack ) Moye, Joseph A. Church, Hans ML Spiegel, Terence Fenton, Elizabeth (Betsy) Smith, Bobbie L. Graham, Courtney V. FletcherPharmacokinetics and 24-week efficacy and safety of lopinavir/ritonavir in HIV-1-infected infants < 6 weeks of age.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1030
Authors
Jorge Pinto, Brian Robbins, Jie (Ellen) Chen, Leslie Serchuck, Edmund Capparelli, Ram Yogev, Paul Palumbo, John H. Rodman, Barbara E. Heckman, Ellen Gould ChadwickPsychotropic drug therapy and psychiatric symptoms in HIV-infected and uninfected children and adolescents enrolled in PACTG P1055.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1055
Authors
Miriam Chernoff, Sharon Appelbaum Nachman, Paige L. Williams, Pim Brouwers, Jerry D. Heston, Janice Hodge, Vincenza M. Di Poalo, Nagamah Sandra Deygoo, Kenneth D. GadowLopinavir protein binding during pregnancy.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1026S
Authors
Francesca Aweeka, Alice M. Stek, Brookie M. Best, ChengCheng Hu, Diane Holland, Ashwaq E. Hermes, Sandra K. Burchett, Jennifer S. Read, Mark Mirochnick, Edmund CapparelliCYP2B6-G516T genetic variants affect the pharmacokinetics of nevirapine and clinical responses in HIV-1 infected children receiving HAART.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Authors
Akihiko Saitoh, Elizabeth Sarles, Edmund Capparelli, Francesca Aweeka, Andrea Kovacs, Sandra K. Burchett, Andrew A. Wiznia, Sharon Appelbaum Nachman, Terence Fenton, Stephen A. SpectorDelayed recovery of HIV-specific CD4-mediated immunity in HIV-infected children on their first HAART regimen (PACTG P1021)
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1021
Authors
Adriana Weinberg, Paula Britto, ChengCheng Hu, Ruth E. Dickover, Julie A. Patterson, Howard Gutzman, Mobeen H. Rathore, Ross E. McKinneyThe PACTG 1020A protocol: atazanavir with or without ritonavir in HIV-infected infants, children, and adolescents.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1020A
Authors
Richard M. Rutstein, Pearl Samson, Jennifer J. Kiser, Courtney V. Fletcher, Bobbie L. Graham, Steven M. Schnittman, Elizabeth (Betsy) Smith, Lynne M. Mofenson, Terence Fenton, Grace M. AldrovandiTenofovir pharmacokinetics during pregnancy, at delivery and postpartum.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1026S